Original ArticlesVenous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: A survey of the AAHKS membership☆,☆☆
Section snippets
Methods
A unique group of orthopaedic surgeons, who performed a minimum of 50 THA and TKA operations per year and were members of the American Association of Hip and Knee Surgeons (AAHKS), were mailed a 15-question survey developed by the AAHKS Research Committee. The American Academy of Orthopaedic Surgeons (AAOS) research department assisted in the survey design to facilitate scanning and data tabulation (see Appendix). The major elements of the questionnaire related to current choices and duration
Surgeon demographics
The surgeon's practice setting was an orthopaedic group in 78% (183 of 236), a multispecialty group in 14% (32 of 236), and solo practice in 9% (21 of 236). Of respondents, 76% (180 of 236) were in a private practice environment, whereas 19% (46 of 236) were in an academic environment. Two percent (5 of 236) were employees of a hospital, 2% (4 of 236) were employees of a health maintenance organization or prepaid plan, and 0.4% (1 of 236) were employees of the U.S. government in the armed
Discussion
Many surveys of surgeon practices regarding VTED prophylaxis have been published 1, 2, 3, 4, 5. The general surgical literature suggests an increased use of prophylactic agents in more recent years compared with earlier times in commonly performed procedures among surgeons who responded to the surveys. In 1982, Conti and Daschehbach [3] sent 994 general surgeons a survey that included 10 hypothetical clinical situations illustrating variable risks of deep venous thrombosis and asked for the
Acknowledgements
We thank the members of the AAHKS who completed and returned this survey, making this report possible. We also thank Wanda Swenson for her editorial assistance.
References (28)
- et al.
Prevention of venous thromboembolism in North America: results of a survey among general surgeons
J Vasc Surg
(1994) - et al.
Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis
J Arthroplasty
(1999) - et al.
Antithrombotic practice in orthopedic surgery: results of a survey
Clin Orthop
(1974) - et al.
Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery
Clin Orthop
(1997) - et al.
Venous thrombosis prophylaxis, a survey of its use in the United States
Arch Surg
(1982) - et al.
Prevention of venous thrombosis
Chest
(1998) - et al.
The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty
J Bone Joint Surg Am
(1997) - et al.
Hip arthroplasty: postoperative management problems: a global approach to management in total hip and knee arthroplasty
Orthopedics
(1999) - et al.
Comparison of enoxaparin and warfarin for the prevention of venous thrombotic disease after total hip arthroplasty: evaluation during hospitalization and three months after discharge
J Bone Joint Surg Am
(1999) - et al.
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement
J Bone Joint Surg Am
(1994)
Prevention of deep-vein thrombosis after total hip arthroplasty
J Bone Joint Surg Am
Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty
J Bone Joint Surg Br
Low molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
N Engl J Med
Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement: a double-blind, dose-ranging study
Thromb Haemost
Cited by (56)
The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty
2017, Thrombosis ResearchCitation Excerpt :Subsequent studies in more contemporaneous populations, both in observational cohorts as well as studies of multimodal interventions to prevent VTE after arthroplasty, have found aspirin to be a reasonable choice in some patients [19–22]. At present, anticoagulants continue to remain the most common form of VTE prevention used in the United States, despite updated national guidelines that allow for the use of aspirin [4,5,23,24]. In part, this may be due to the challenges in being able to accurately risk-stratify patients undergoing arthroplasty according to VTE risk.
Venous Thromboembolism. Management by American Association of Hip and Knee Surgeons
2010, Journal of ArthroplastyVenous Thromboembolic Disease Reduction With a Portable Pneumatic Compression Device
2009, Journal of ArthroplastyShould Thromboprophylaxis be Used for Lower Limb Joint Replacement Surgery?
2009, Evidence-Based Orthopaedics: The Best Answers to Clinical Questions
- ☆
No benefits or funds were received in support of this study.
- ☆☆
Reprint requests: J. Wesley Mesko, MD, Michigan Orthopedic Center, 2901 Stabler Street, Lansing, MI 48910. E-mail: [email protected]